← FDA Drug Approvals (Drugs@FDA)

ERYTHROMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 1996-07-03

Drug application

FDA Application #

ANDA064128

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERYTHROMYCIN

Generic name

Erythromycin

Active ingredients

ERYTHROMYCIN

Dosage form

SWAB

Route

TOPICAL

Marketing status

Discontinued

Sponsor

PHARMOBEDIENT

First approval

1996-07-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown